Natural Bactericidal Activity of Human Serum Against Neisseria Meningitidis Isolates of Different Serogroups and Serotypes

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1982 Jul 1

PMID 6809622

Citations 8

Authors

D E Craven

K T Shen

C E Frasch

Affiliations

Soon will be listed here.

Abstract

We used a microtiter assay, standardized with serum-sensitive and serum-resistant strains of Neisseria gonorrhoeae, to determine the serum sensitivity of Neisseria meningitidis isolates of different serogroups and serotypes. Numbers of serum-resistant isolates varied among serogroups: group A = 7/8 (88%), group B = 26/50 (52%), group C = 5/8 (63%), group Y = 4/6 (67%), group W135 = 5/8 (63%), group 29E (Z') = 0/8 (0%), nongroupable isolates = 0/8 (0%). In comparison to group B isolates, group A isolates were more serum resistant (P less than 0.06), and group 29E and nongroupable isolates were more serum sensitive (P less than 0.001). Poor correlation was observed between serum sensitivity results and group-specific levels of bactericidal antibody in the normal human serum of volunteers. The frequency of serum-resistant strains among group B disease isolates (45%) was not significantly different from throat isolates of asymptomatic carriers (52%). Serotype 2 isolates of group B were no more serum resistant than were other serotypes examined. The serum sensitivity of meningococci appears to involve both capsular and noncapsular antigens and varies between serogroups. The increased serum sensitivity of nongroupable and group 29E isolates may account for the low incidence of disease caused by these organisms.

Citing Articles

Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method.

Jang M, Sahastrabuddhe S, Yun C, Han S, Yang J Microb Pathog. 2016; 97:19-26.

PMID: 27216239 PMC: 4944902. DOI: 10.1016/j.micpath.2016.05.013.

Standardization of Neisseria meningitidis serogroup B colorimetric serum bactericidal assay.

Rodriguez T, Lastre M, Cedre B, Del Campo J, Bracho G, Zayas C Clin Diagn Lab Immunol. 2002; 9(1):109-14.

PMID: 11777839 PMC: 119898. DOI: 10.1128/cdli.9.1.109-114.2002.

Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.

Maslanka S, Gheesling L, Libutti D, Donaldson K, Harakeh H, Dykes J Clin Diagn Lab Immunol. 1997; 4(2):156-67.

PMID: 9067649 PMC: 170495. DOI: 10.1128/cdli.4.2.156-167.1997.

Human opsonins to meningococci after vaccination.

Halstensen A, Haneberg B, Froholm L, Lehmann V, Frasch C, SOLBERG C Infect Immun. 1984; 46(3):673-6.

PMID: 6437988 PMC: 261595. DOI: 10.1128/iai.46.3.673-676.1984.

Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.

Zollinger W, Mandrell R Infect Immun. 1983; 40(1):257-64.

PMID: 6403466 PMC: 264843. DOI: 10.1128/iai.40.1.257-264.1983.

References

MUSCHEL L . Serum bactericidal actions. Ann N Y Acad Sci. 1960; 88:1265-72. DOI: 10.1111/j.1749-6632.1960.tb20117.x. View

Frasch C, ROBBINS J . Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. J Exp Med. 1978; 147(3):629-44. PMC: 2184206. DOI: 10.1084/jem.147.3.629. View

Zollinger W, Mandrell R . Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay. Infect Immun. 1977; 18(2):424-33. PMC: 421250. DOI: 10.1128/iai.18.2.424-433.1977. View

Goldschneider I, Gotschlich E, Artenstein M . Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969; 129(6):1307-26. PMC: 2138650. DOI: 10.1084/jem.129.6.1307. View

Craven D, Peppler M, Frasch C, Mocca L, McGrath P, Washington G . Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis. 1980; 142(4):556-68. DOI: 10.1093/infdis/142.4.556. View

Sippel J, Quan A . Homogeneity of protein serotype antigens in Neisseria meningitidis group A. Infect Immun. 1977; 16(2):623-7. PMC: 421002. DOI: 10.1128/iai.16.2.623-627.1977. View

Tramont E, Sadoff J, Artenstein M . Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction. J Infect Dis. 1974; 130(3):240-7. DOI: 10.1093/infdis/130.3.240. View

McCabe W, Kaijser B, Olling S, Uwaydah M, Hanson L . Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis. 1978; 138(1):33-41. DOI: 10.1093/infdis/138.1.33. View

SPINK W, Keefer C . STUDIES OF GONOCOCCAL INFECTION. II. THE BACTERIOLYTIC POWER OF THE WHOLE DEFIBRINATED BLOOD OF PATIENTS WITH GONOCOCCAL ARTHRITIS. J Clin Invest. 1937; 16(2):177-83. PMC: 424858. DOI: 10.1172/JCI100845. View

10.

Thomas L, DINGLE J . INVESTIGATIONS OF MENINGOCOCCAL INFECTION. III. THE BACTERICIDAL ACTION OF NORMAL AND IMMUNE SERA FOR THE MENINGOCOCCUS. J Clin Invest. 1943; 22(3):375-85. PMC: 435250. DOI: 10.1172/JCI101406. View

11.

AYCOCK W, Mueller J . Meningococcus carrier rates and meningitis incidence. Bacteriol Rev. 1950; 14(2):115-60. PMC: 440962. DOI: 10.1128/br.14.2.115-160.1950. View

12.

Roantree R, RANTZ L . A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION. J Clin Invest. 1960; 39(1):72-81. PMC: 290665. DOI: 10.1172/JCI104029. View

13.

Schoolnik G, Ochs H, Buchanan T . Immunoglobulin class responsible for gonococcal bactericidal activity of normal human sera. J Immunol. 1979; 122(5):1771-9. View

14.

Goldschneider I, Gotschlich E, Artenstein M . Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med. 1969; 129(6):1327-48. PMC: 2138665. DOI: 10.1084/jem.129.6.1327. View

15.

Rice P, McCormack W, Kasper D . Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease. J Immunol. 1980; 124(5):2105-9. View

16.

Vosti K, Randall E . Sensitivity of serologically classified strains of escherichia coli of human origin to the serum bactericidal system. Am J Med Sci. 1970; 259(2):114-9. DOI: 10.1097/00000441-197002000-00005. View

17.

Griffiss J . Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera. J Immunol. 1975; 114(6):1779-84. View

18.

FRISCH A . The meningococcidal power of heparinized blood for group B organisms. Am J Clin Pathol. 1968; 50(2):221-8. DOI: 10.1093/ajcp/50.2.221. View

19.

GLYNN A, Ward M . Nature and Heterogeneity of the Antigens of Neisseria gonorrhoeae Involved in the Serum Bactericidal Reaction. Infect Immun. 1970; 2(2):162-8. PMC: 415984. DOI: 10.1128/iai.2.2.162-168.1970. View

20.

Michael J, WHITBY J, Landy M . Studies on natural antibodies to gram-negative bacteria. J Exp Med. 1962; 115:131-46. PMC: 2137482. DOI: 10.1084/jem.115.1.131. View